PhD, Public Health
University of Massachusetts, Amherst
My research is focused on examining associations between biomarkers, modifiable lifestyle factors, and breast cancer risk.
Devore EE, Warner ET, Eliassen AH, Brown SB, Beck AH, Hankinson SE, Schernhammer ES. Urinary melatonin in relation to postmenopausal breast cancer risk according to melatonin 1 receptor status. Cancer Epidemiol Biomarkers Prev 2017;26(3):413-419.
Brown SB, Hankinson SE, Arcaro KF, Qian J, Reeves KW. Depression, antidepressant use, and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2016;25(1):158-64.
Brown SB, Hankinson SE, Eliassen AH, Reeves KW, Qian J, Arcaro KF, Wegrzyn LR, Willett WC, Schernhammer ES. Urinary melatonin concentration and the risk of breast cancer in the Nurses’ Health Study II. Am J Epidemiol 2015;181(3):155-62.
Brown SB, Hankinson SE. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers. Steroids 2015;99:8-10.
Ramin C, Massa J, Wegrzyn LR, Brown SB, Pierre-Paul J, Devore EE, Hankinson SE, Schernhammer ES. The association of body size in early to mid-life with adult urinary 6-sulfatoxymelatonin levels among night shift health care workers. BMC Public Health 2015;15:467.
Cancer epidemiology, women’s health